Taste Alteration with Antiparkinsonian Medications
Evidence for Taste Changes in Parkinson's Disease Treatment
- Changes in taste and smell have been reported by Parkinson's disease patients as contributing factors to weight loss, alongside other gastrointestinal side effects of antiparkinsonian medications 1
- Side effects of drugs prescribed for PD that influence nutritional status include nausea, vomiting, abdominal pain, dyspepsia, constipation, weight decrease, dry mouth, diarrhea, anorexia, and GI disorders 1
- The ESPEN guideline specifically recommends monitoring side effects of antiparkinsonian drugs that might influence nutritional status and intervening on an individually tailored basis 1
Clinical Management Approach
Monitoring Strategy
- Assess nutritional status regularly, as weight loss is common in Parkinson's disease patients and may be exacerbated by taste alterations 2
- Monitor for specific side effects including changes in taste perception, dry mouth, and anorexia when prescribing levodopa or other antiparkinsonian agents 1
- Increasing doses of levodopa and levodopa equivalent doses are associated with increased risk for malnutrition, requiring closer nutritional monitoring 1
Nutritional Interventions
- Optimize antiparkinsonian treatment to ameliorate motor symptoms that contribute to dysphagia and nutritional problems 1
- Increased fiber and fluid intake, along with probiotics, can help manage constipation that may compound nutritional issues 2
- For levodopa specifically, give attention to homocysteine levels and vitamin B status, as levodopa use may be associated with impaired nutritional status 1, 3